Collett Jason A, Corridon Peter R, Mehrotra Purvi, Kolb Alexander L, Rhodes George J, Miller Caroline A, Molitoris Bruce A, Pennington Janice G, Sandoval Ruben M, Atkinson Simon J, Campos-Bilderback Silvia B, Basile David P, Bacallao Robert L
Department of Cellular and Integrative Physiology.
Department of Craniofacial Biology, University of Colorado Denver, Anschutz Campus, Aurora, Colorado.
J Am Soc Nephrol. 2017 Jul;28(7):2081-2092. doi: 10.1681/ASN.2016040404. Epub 2017 Jan 25.
Highly aerobic organs like the kidney are innately susceptible to ischemia-reperfusion (I/R) injury, which can originate from sources including myocardial infarction, renal trauma, and transplant. Therapy is mainly supportive and depends on the cause(s) of damage. In the absence of hypervolemia, intravenous fluid delivery is frequently the first course of treatment but does not reverse established AKI. Evidence suggests that disrupting leukocyte adhesion may prevent the impairment of renal microvascular perfusion and the heightened inflammatory response that exacerbate ischemic renal injury. We investigated the therapeutic potential of hydrodynamic isotonic fluid delivery (HIFD) to the left renal vein 24 hours after inducing moderate-to-severe unilateral IRI in rats. HIFD significantly increased hydrostatic pressure within the renal vein. When conducted after established AKI, 24 hours after I/R injury, HIFD produced substantial and statistically significant decreases in serum creatinine levels compared with levels in animals given an equivalent volume of saline peripheral infusion (<0.05). Intravital confocal microscopy performed immediately after HIFD showed improved microvascular perfusion. Notably, HIFD also resulted in immediate enhancement of parenchymal labeling with the fluorescent dye Hoechst 33342. HIFD also associated with a significant reduction in the accumulation of renal leukocytes, including proinflammatory T cells. Additionally, HIFD significantly reduced peritubular capillary erythrocyte congestion and improved histologic scores of tubular injury 4 days after IRI. Taken together, these results indicate that HIFD performed after establishment of AKI rapidly restores microvascular perfusion and small molecule accessibility, with improvement in overall renal function.
像肾脏这样需氧程度高的器官天生就易受缺血再灌注(I/R)损伤,这种损伤可能源于心肌梗死、肾外伤和移植等多种情况。治疗主要是支持性的,取决于损伤的原因。在不存在血容量过多的情况下,静脉输液常常是首要治疗手段,但并不能逆转已发生的急性肾损伤(AKI)。有证据表明,破坏白细胞黏附可能会预防肾微血管灌注受损以及加剧缺血性肾损伤的炎症反应增强。我们研究了在大鼠中度至重度单侧缺血再灌注损伤(IRI)诱导24小时后,经流体动力学方法向左肾静脉输注等渗液体(HIFD)的治疗潜力。HIFD显著增加了肾静脉内的静水压。在缺血再灌注损伤24小时后已发生AKI时进行HIFD,与给予等量生理盐水外周输注的动物相比,HIFD使血清肌酐水平大幅且有统计学意义地降低(<0.05)。HIFD后立即进行的活体共聚焦显微镜检查显示微血管灌注得到改善。值得注意的是,HIFD还导致用荧光染料Hoechst 33342对实质的标记立即增强。HIFD还与肾白细胞(包括促炎性T细胞)的积聚显著减少相关。此外,HIFD显著减轻了肾小管周围毛细血管红细胞淤滞,并改善了缺血再灌注损伤4天后肾小管损伤的组织学评分。综上所述,这些结果表明在AKI形成后进行HIFD可迅速恢复微血管灌注和小分子可及性,并改善整体肾功能。